MSH6 and endometrial cancer: Endometrial cancer has a prevalence of 3% in patients with Lynch syndrome and is the most frequently observed cancer in women harboring pathogenic MSH6 variants, with a 41% risk of developing endometrial cancer by age 70 (98, 99).